Atlas Venture Life Science Advisors’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $277M | Hold |
|
|||||
|
2025
Q2 | $214M | Hold |
|
|||||
|
2025
Q1 | $134M | Hold |
|
|||||
|
2024
Q4 | $197M | Hold |
|
|||||
|
2024
Q3 | $232M | Sell |
|
|||||
|
2024
Q2 | $160M | Sell |
|
|||||
|
2024
Q1 | $216M | Sell |
|
|||||
|
2023
Q4 | $149M | Hold |
|
|||||
|
2023
Q3 | $81.4M | Hold |
|
|||||
|
2023
Q2 | $135M | Hold |
|
|||||
|
2023
Q1 | $174M | Sell |
|
|||||
|
2022
Q4 | $149M | Sell |
|
|||||
|
2022
Q3 | $150M | Hold |
|
|||||
|
2022
Q2 | $135M | Hold |
|
|||||
|
2022
Q1 | $291M | Hold |
|
|||||
|
2021
Q4 | $437M | Buy |
|